Skip to main content

Joanna Schwartz, PharmD, BCOP

Authored Items

New Developments in the Management of Hand-Foot Syndrome Associated With Oral Anti-VEGF Tyrosine Kinase Inhibitor–Targeted Anticancer Therapies
By Joanna Schwartz, PharmD, BCOP; Shannon Hogan, PharmD
TOP - May 2013, Vol 6, No 2
Supportive Care
Hand-foot skin reaction (HFSR), also known as hand-foot syndrome or palmar-plantar erythrodysesthesia (PPE), is an adverse effect of several chemotherapeutic agents. Read More ›